chenodeoxycholic acid leadiant (previously known as chenodeoxycholic acid sigma-tau)
leadiant gmbh - chenodeoxycholic acid - xanthomatosis, cerebrotendinous; metabolism, inborn errors - bile and liver therapy - chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.
chenodeoxycholic acid leadiant
mbi pharma ltd., israel - chenodeoxycholic acid - hard capsule - chenodeoxycholic acid 250 mg - chenodeoxycholic acid - the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (ctx)) in infants, children and adolescents aged 1 month to 18 years and adults.
chenodeoxycholic acid 250mg capsules
special order - chenodeoxycholic acid - capsule - 250mg
chenodeoxycholic acid 200mg tablets
special order - chenodeoxycholic acid - tablet - 200mg
chenodeoxycholic acid 250mg capsules
leadiant biosciences ltd - chenodeoxycholic acid - capsule - 250mg
chendol
artex limited - chenodeoxycholic acid 125mg - capsule - 125 mg - active: chenodeoxycholic acid 125mg
kebilis
sanofi-aventis new zealand limited - chenodeoxycholic acid 250mg - tablet - 250 mg - active: chenodeoxycholic acid 250mg
chenodiol 250mg tablets
imported (canada) - chenodeoxycholic acid - oral tablet - 250mg
xenbilox 250mg capsules
imported (germany) - chenodeoxycholic acid - oral capsule - 250mg
chino capsules 125 (チノカプセル125)
fujimoto pharmaceutical corporation - chenodeoxycholic acid - green capsule, major axis:15.8 mm, minor axis:5.8 mm